Commonwealth Equity Services Inc trimmed its holdings in shares of Monsanto Company (NYSE:MON) by 5.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,398 shares of the basic materials company’s stock after selling 3,771 shares during the period. Commonwealth Equity Services Inc’s holdings in Monsanto were worth $7,955,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in MON. Fic Capital Inc. acquired a new stake in Monsanto during the 1st quarter valued at $208,000. BlackRock Inc. increased its holdings in Monsanto by 2,390.1% during the 1st quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after purchasing an additional 25,140,936 shares in the last quarter. King Luther Capital Management Corp increased its stake in shares of Monsanto by 2.2% in the 1st quarter. King Luther Capital Management Corp now owns 948,985 shares of the basic materials company’s stock valued at $107,425,000 after buying an additional 19,981 shares during the period. KCG Holdings Inc. acquired a new stake in shares of Monsanto in the 1st quarter valued at $1,886,000. Finally, United Capital Financial Advisers LLC increased its stake in shares of Monsanto by 2.7% in the 1st quarter. United Capital Financial Advisers LLC now owns 8,886 shares of the basic materials company’s stock valued at $1,006,000 after buying an additional 230 shares during the period. 74.50% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (MON) traded down $0.27 during mid-day trading on Friday, reaching $118.33. The company’s stock had a trading volume of 936,517 shares, compared to its average volume of 1,938,845. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $52,210.00, a price-to-earnings ratio of 21.35, a PEG ratio of 1.70 and a beta of 1.05. Monsanto Company has a 52-week low of $100.29 and a 52-week high of $122.79.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.07 earnings per share. sell-side analysts expect that Monsanto Company will post 5.74 earnings per share for the current year.
MON has been the subject of several research reports. Royal Bank Of Canada reissued a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research note on Wednesday, August 2nd. Vetr cut Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a research note on Wednesday, August 2nd. Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research note on Friday, August 11th. UBS AG cut Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price for the company. in a research note on Friday, August 18th. Finally, BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $124.61.
WARNING: “Monsanto Company (MON) Position Trimmed by Commonwealth Equity Services Inc” was posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.truebluetribune.com/2017/11/18/monsanto-company-mon-position-trimmed-by-commonwealth-equity-services-inc.html.
In other Monsanto news, VP Nicole M. Ringenberg sold 7,890 shares of Monsanto stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the transaction, the vice president now directly owns 38,600 shares in the company, valued at $4,718,850. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the transaction, the chief financial officer now owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 49,236 shares of company stock worth $5,931,934. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.